Ann Intern Med

1. SACKS HS
   In older adults, high- vs. standard-dose influenza vaccine reduced hospitalization for influenza or pneumonia in those with CKD.
   Ann Intern Med. 2026 Mar 3. doi: 10.7326/ANNALS-26-00324.
   

   >> Share

   
   
2. ANAND R, Glatt AE
   In healthy adults, a modified RNA vs. inactivated influenza vaccine reduced laboratory-confirmed influenza-like illness at >/=14 d.
   Ann Intern Med. 2026 Mar 3. doi: 10.7326/ANNALS-25-05681.
   

   >> Share

   
   

   
   Antiviral Res

3. RUDRAMURTHY GR, Gudla CS, Harisha R, Selvam V, et al
   FNDR-11124, a broad-spectrum small molecule inhibitor of viral RNA polymerase, restricts replication of SARS-CoV-2 and Influenza virus in vitro and in vivo.
   Antiviral Res. 2026 Mar 2:106382. doi: 10.1016/j.antiviral.2026.106382.
   

   >> Share

   
   

   
   Arch Virol

4. DUTTA M, Sarmah N, Siddique AI, Borah P, et al
   Temporal trends and burden of influenza B virus lineages in Dibrugarh, Assam (2014-2025): predominance of Victoria with early circulation of Yamagata.
   Arch Virol. 2026;171:110.
   

   >> Share

   
   

   
   J Gen Virol

5. GROSS J, Pouget B, Sarrat M, Foret-Lucas C, et al
   In vivo inhibition of JAK-STAT signalling enhances high pathogenicity influenza virus replication in ducks.
   J Gen Virol. 2026;107:002238.
   

   >> Share

   
   

   
   J Immunol

6. WERNINGHAUS IC, Hinke DM, Katta K, Bogen B, et al
   A combinatorial DNA vaccine encoding APC-targeted, bivalent HA and NA antigens results in an improved influenza vaccine.
   J Immunol. 2026;215:vkaf378.
   

   >> Share

   
   
7. SHARMA SB, Kumar K, Parchment N, Eggleston T, et al
   Viral-specific induction of cellular and soluble urokinase plasminogen activator receptor (suPAR) expression.
   J Immunol. 2026;215:vkaf365.
   

   >> Share

   
   
8. SOUDANI N, Sidney J, Da Silva Antunes R, Case JB, et al
   Identification of immunodominant T cell epitopes in SARS-CoV-2 spike protein in Syrian hamsters.
   J Immunol. 2026;215:vkaf342.
   

   >> Share

   
   

   
   J Infect Dis

9. WANG L, Wang J, Hossain J, Cooper HC, et al
   Development and Characterization of Candidate Vaccine Viruses against High Pathogenicity Avian Influenza A(H5) Viruses for Rapid Pandemic Response.
   J Infect Dis. 2026 Feb 28:jiag132. doi: 10.1093.
   

   >> Share

   
   

   
   N Engl J Med

10. GABET A, Bernard C, Zureik M
    Updated Evidence Base for Covid-19, RSV, and Influenza Immunizations.
    N Engl J Med. 2026;394:10.
    

    >> Share

    
    

    
    Pediatrics

11. TSUNG S, Zeng YB, Shah K, Asch SM, et al
    Cost-Effectiveness of Nirsevimab and Maternal RSVpreF Immunization Strategies in Low-Risk Infants.
    Pediatrics. 2026 Feb 20:e2025071558. doi: 10.1542/peds.2025-071558.
    

    >> Share

    
    

    
    PLoS Comput Biol

12. CRAIG M, Deng X, McLeod DV
    Viral evolution during primary infection in immunocompromised hosts.
    PLoS Comput Biol. 2026;22:e1013967.
    

    >> Share

    
    

    
    PLoS One

13. RAHIMNAHAL S, Yousefizadeh S, Mohammadi Y
    Designing a novel vaccine against COVID-19 based on spike SARS-Cov-2 notable mutations using immunoinformatics approaches.
    PLoS One. 2026;21:e0334662.
    

    >> Share

    
    
14. RATREE S, Assavapokee N, Santibenchakul S, Sirisabya N, et al
    Reported adverse events following COVID-19 vaccination in gynecologic cancer patients in Thailand: A descriptive study.
    PLoS One. 2026;21:e0342303.
    

    >> Share

    
    
15. DEMPSEY LF, Osuka H, McGovern OL, Munita JM, et al
    Antimicrobial use and documented infection among hospitalized adults in South American acute care facilities during the coronavirus disease 2019 (COVID-19) pandemic.
    PLoS One. 2026;21:e0343535.
    

    >> Share

    
    
16. SHKOLNIKOV VM, Timonin S, Jdanov D, Medina-Jaudes N, et al
    Widening East-West inequality in life expectancy in Europe during the COVID-19 pandemic: An international comparative study.
    PLoS One. 2026;21:e0344003.
    

    >> Share

    
    
17. MEYER F, Traidl S, Ameri M, Dreher A, et al
    Distinguishing post-COVID from long-COVID in adults: Development and validation of a biomarker signature using targeted proteomics and machine learning in a cross-sectional observational study.
    PLoS One. 2026;21:e0338451.
    

    >> Share

    
    
18. FIAZ N, Basheer A, Zahoor I, Naveed S, et al
    Distinct mutational landscapes and phylogenomic insights of the SARS-CoV-2 delta variant in Pakistan and India: Regional evolution, novel mutations, and epidemiological implications.
    PLoS One. 2026;21:e0340704.
    

    >> Share

    
    
19. GUTIERREZ-SIGUT E, Lamarche V, Rowley K, Lago EF, et al
    Access to information in deaf and hard-of-hearing people.
    PLoS One. 2026;21:e0343904.
    

    >> Share

    
    
20. PAVON R, Parra S, Rubio FJ, Feliu M, et al
    Assessment of physical status and analysis of lipidomic and metabolomic alterations in patients with Post-COVID-19 condition.
    PLoS One. 2026;21:e0341192.
    

    >> Share

    
    

    
    Virology

21. BARMAN S, Iyengar R, Miller L, Turner JCM, et al
    Reverse genetic rescue and propagation of human influenza A(H3N2) master virus seed in HEK-293 suspension cells.
    Virology. 2026;618:110862.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share